Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-008963
Filing Date
2002-03-07
Accepted
2002-03-07 00:00:00
Documents
12
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2071755z10-k.txt 10-K 250392
3 EXHIBIT 10-43 a2071755zex-10_43.txt EX-10.43 15559
4 EXHIBIT 10-44 a2071755zex-10_44.txt EX-10.44 74871
5 EXHIBIT 10.45 a2071755zex-10_45.txt EX-10.45 147431
6 EXHIBIT 10.46 a2071755zex-10_46.txt EX-10.46 50498
7 EXHIBIT 10.47 a2071755zex-10_47.txt EX-10.47 9115
8 EXHIBIT 10.48 a2071755zex-10_48.txt EX-10.48 45773
9 EXHIBIT 10.49 a2071755zex-10_49.txt EX-10.49 7872
10 EXHIBIT 10-50 a2071755zex-10_50.txt EX-10.50 28591
11 EXHIBIT 10.51 a2071755zex-10_51.txt EX-10.51 31479
12 EXHIBIT 23.1 a2071755zex-23_1.txt EX-23.1 476
13 EXHIBIT 99.1 a2071755zex-99_1.txt EX-99.1 38030
  Complete submission text file 0000912057-02-008963.txt   702908
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30981 | Film No.: 02568784
SIC: 8731 Services-Commercial Physical & Biological Research